Skip to content
Recall Observatory FDA recall evidence

Drug product

Major ChlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 Tablets, (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7131-61, UPC (01)00309047131617

D-0011-2026

September 12, 2025

Class II

Product summary

Firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Event
Event 97584
Status
Ongoing
Classification
Class II
Quantity
506 blister packs
Official record key
drug-enforcement:D-0011-2026

Official wording

Reason: CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

Code information: Lots N02009 & N02026, exp. date 02/28/2026

Distribution pattern: Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations